We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Molecular Method Identifies Six Sexually Transmitted Pathogens

By LabMedica International staff writers
Posted on 10 May 2011
A multiplex polymerase chain reaction (PCR)-based auto-capillary electrophoresis (ACE) system can distinguish six pathogens that are transmitted during sexual contact. More...


The method combines a nucleic acid amplification technique with a fully automated electrophoretic device and was developed to simplify the analysis of multiplex PCR assays and to provide accurate amplicon sizing with automated interpretation of pathogen identity.

Scientists at the Rabin Medical Center, (Petach Tikva, Israel), screened genital/urinary specimens collected from 113 patients, 72 male and 41 female, with a sexually transmitted infection. The pathogens investigated were: Chlamydia trachomatis, Mycoplasma hominis, M. genitalium, Neisseria gonorrhoeae, Trichomonas vaginalis, and the genital Ureaplasma, (U. urealyticum and U. parvum). The method used a dual priming oligonucleotide (DPO) PCR system, the Seeplex STD6B ACE. The amplified PCR products were separated and detected by the TapeStation automated gel electrophoresis-detection system. The results were compared with conventional reference methods, including culture and PCR tests.

The sensitivity of STD6B ACE assay was found to be 100% for five of the pathogens and 98% for genital Ureaplasma. A single pathogen was detected in 51 specimens, and two or more pathogens were detected in 24 samples. The specificity of the assays ranged from 97% to 100%. The most prevalent pathogen overall was Ureaplasma, which was identified in 42.5% specimens. N. gonorrhoeae was eight-fold more prevalent in men than in women, whereas M. hominis was more prevalent in women, 21.9% versus 5.6% in men. The automated Seeplex STD6B ACE multiplex PCR is a product of Seegene (Seoul, Korea), and the automated gel electrophoresis system TapeStation, is manufactured by Lab901 Ltd. (Bilston Glen, Loanhead, UK).

The authors concluded that the multiplex PCR and ACE system is highly sensitive and specific for the rapid, simultaneous detection of sexually transmitted pathogens directly from a single specimen. The STD6B ACE system uses prepackaged reagents and is rationally automated, which simplifies the analysis of multiplex PCR assays, eliminating the need for time- and labor-consuming agarose gel electrophoresis and thereby improving laboratory workflow. Application of the system may facilitate the diagnosis, treatment, and care of patients with sexually transmitted diseases and help to prevent the spread of these infections. The study was published in May 2011 in the journal Diagnostic Microbiology and Infectious Disease.

Related Links:
Rabin Medical Center
Seegene
Lab901 Ltd.


Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Parainfluenza Virus Test
PARAINFLUENZA ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.